publication venue for
- 3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study.. 385. 1994
- Peripheral blood mononuclear mobilization with sargramostim (GM-CSF).. 389. 1994
- Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.. 385. 1994
- New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results.. 377. 1992
- Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.. 377. 1992
- The AIS CELLector: a new technology for stem cell purification.. 377. 1992
- 131I-3F8: clinical validation of imaging studies and therapeutic applications.. 366. 1991
- Efficient killing of neuroblastoma cells by human monocytes activated with recombinant human macrophage colony-stimulating factor and anti-tumor antibody.. 366. 1991
- Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial.. 366. 1991
- Stage IV neuroblastoma more than 1 year of age at diagnosis: major response to chemotherapy and survival durations correlated strongly with dose intensity.. 366. 1991
- Characterization of human hematopoietic stem cells.. 352. 1990
- Immunoregulatory effects of alcohol on lymphocyte responses to human immunodeficiency virus proteins.. 325. 1990
- In vitro fertilization and embryo transfer: an established and successful therapy for endometriosis.. 323. 1990
- M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation.. 353. 1990
- Tyrosine hydroxylase and enkephalin in nuclei of the solitary tracts: co-existence and convergent synaptic input to catecholamine neurons.. 328. 1990
- Tyrosine hydroxylase and enkephalin in the rostral ventrolateral medulla: major synaptic contacts from opioid terminals on catecholaminergic neurons.. 328. 1990
- Vascular uptake of 111-In-platelets and of 123-I-LDL.. 355. 1990
- A molecular theoretical model of recognition and activation at a 5-HT receptor.. 289. 1989
- A monoclonal antibody (B72.3) to adenocarcinoma of the colon and related tumors.. 288. 1989
- Adriamycin versus BCG in superficial bladder cancer: a Southwest Oncology Group Study.. 310. 1989
- Is radiotherapy effective for locally advanced (stage C or T3) prostate cancer?. 303. 1989
- Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor response.. 303. 1989
- Regulatory protein action in the neighborhood of chicken globin genes during development.. 316A. 1989
- Transplantation of retinal epithelium prevents photoreceptor degeneration in the RCS rat.. 314. 1989
- Treatment of human metastatic melanoma with mouse monoclonal antibodies against GD3 ganglioside.. 288. 1989
- In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study.. 271. 1988
- Iodine 131 labeled GD2 monoclonal antibody in the diagnosis and therapy of human neuroblastoma.. 271. 1988
- The advanced cancer patient--a clinical profile.. 278. 1988
- Combined interstitial and external irradiation for prostatic cancer.. 243B. 1987
- Effects of adenosine on ventricular tachycardia.. 230. 1987
- Phenotype and functional characterization of NK and LAK cells following T-depleted bone marrow transplantation.. 244. 1987
- Role of second messengers in regulating the growth-associated S6 protein kinase activity.. 249. 1987
- The regulation of collagen type IV(alpha 1) and other genes during the retinoic acid induced differentiation of wild type and mutant mouse teratocarcinoma stem cells.. 226. 1986
- A comparative review of the results of transplants of fully allogeneic fetal liver and HLA-haplotype mismatched, T-cell depleted marrow in the treatment of severe combined immunodeficiency.. 193. 1985
- Amplification of N-myc sequences in primary human neuroblastomas: correlation with advanced disease stage.. 175. 1985
- Development of neuroblastoma monoclonal antibodies for potential utilization in diagnosis and therapy.. 175. 1985
- Regulatory role of calcium in sodium transport.. 164. 1984
- Role of Ca++ as a regulator of Na+ permeability in epithelia.. 168. 1984
- The participation of community hospitals in cancer clinical trials: results and impact of the Eastern Cooperative Oncology Group Program.. 120. 1983
- Using retroviruses as insertional mutagens to identify cellular oncogenes.. 119. 1983
- Extracorporeal modification of plasma and whole blood.. 106. 1982
- Some structure activity relationships of phencyclidine derivatives as anticholinergic agents in vitro and in vivo.. 27. 1979
- HLA associations with acute myelogenous leukemia.. 16. 1977
- Cortisol metabolism in the perinatal period.. 10. 1976
- Chemotherapy for invasive bladder tumors. 1990
- Immunotherapy with GD2 specific monoclonal antibodies. 1988
- Chemotherapy-based multi-modality therapy of esophageal cancer. 1985
- The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer model. 1996
- Benign prostatic hyperplasia: dihydrotestosterone and 5 alpha-reductase inhibition therapy. 1994
- Endocrine therapies for BPH: scientific rationale, clinical results, and patient selection. 1994
- Biology of residual breast cancer after therapy: a kinetic interpretation. 1990
- Pathology of bladder cancer: assessment of the primary lesion and response to therapy. 1990
- Advances in testicular cancer--role of chemotherapy. 1988
- Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy. 1988
- Current concepts of the pathogenesis of fibrosis: lessons from pulmonary fibrosis. 1984
- Human bone marrow fibroblast colony-forming units (CFU-F). 1984
- Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components. 1984
- Properties of myelofibrosis-derived fibroblasts. 1984